Moneycontrol
Get App
Last Updated : Apr 20, 2018 01:40 PM IST | Source: Moneycontrol.com

Alembic Pharma Q4 PAT seen up 0.3% YoY to Rs. 90 cr: HDFC Securities

Net Sales are expected to increase by 6.3 percent Y-o-Y (down 6.6 percent Q-o-Q) to Rs. 780 crore, according to HDFC Securities.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

HDFC Securities has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Alembic Pharma to report net profit at Rs. 90 crore up 0.3% year-on-year (down 23.4% quarter-on-quarter).


Net Sales are expected to increase by 6.3 percent Y-o-Y (down 6.6 percent Q-o-Q) to Rs. 780 crore, according to HDFC Securities.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 19.6 percent Y-o-Y (down 14.1 percent Q-o-Q) to Rs. 160 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.




Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Apr 20, 2018 01:40 pm
Sections
Follow us on